MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

Search

Zoetis Inc

Closed

SectorHealthcare

163.53 1.1

Overview

Share price change

24h

Current

Min

160.7

Max

163.62

Key metrics

By Trading Economics

Income

-101M

581M

Sales

-83M

2.3B

P/E

Sector Avg

30.101

63.778

EPS

1.4

Dividend yield

1.21

Profit margin

25.076

Employees

13,800

EBITDA

-133M

906M

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+28.29% upside

Dividends

By Dow Jones

Dividend yield

Sector Avg

1.21%

2.39%

Next Earnings

6 May 2025

Next Ex Dividend date

21 Apr 2025

Market Stats

By TradingEconomics

Market Cap

-5.1B

74B

Previous open

162.43

Previous close

163.53

News Sentiment

By Acuity

29%

71%

87 / 386 Healthcare

Technical Score

By Trading Central

Confidence

Strong Bearish Evidence

Zoetis Inc Chart

Past performance is not a reliable indicator of future results.

Related News

4 Nov 2024, 12:47 UTC

Earnings

Zoetis Lifts Guidance On Strong Demand as 3Q Beats Market Views

6 Aug 2024, 11:52 UTC

Earnings

Zoetis Raises Guidance After 2Q Sales, Earnings Rise

20 Feb 2025, 08:00 UTC

Top News

A Bird-Flu Vaccine Could Bring Down Egg Prices. Why the Poultry Industry Is Fighting It. -- Barrons.com

13 Feb 2025, 13:47 UTC

Earnings

Zoetis Plunges 9% As 2025 Guidance Misses Expectations -- IBD

13 Feb 2025, 12:09 UTC

Earnings

Zoetis Sees FY25 Adj EPS $6-Adj EPS $6.10 >ZTS

13 Feb 2025, 12:08 UTC

Earnings

Zoetis Sees FY25 Rev $9.225B-$9.375B >ZTS

13 Feb 2025, 12:08 UTC

Earnings

Zoetis Sees FY25 EPS $5.70-EPS $5.80 >ZTS

13 Feb 2025, 12:00 UTC

Earnings

Zoetis 4Q EPS $1.29 >ZTS

13 Feb 2025, 12:00 UTC

Earnings

Zoetis 4Q Rev $2.32B >ZTS

13 Feb 2025, 12:00 UTC

Earnings

Zoetis 4Q Net $581M >ZTS

4 Nov 2024, 14:05 UTC

Earnings

Zoetis Barks Up A Third-Quarter Beat And Raise, But Stock Slips -- IBD

4 Nov 2024, 12:06 UTC

Earnings

Zoetis Sees 2024 Rev $9.2B-$9.3B >ZTS

4 Nov 2024, 12:06 UTC

Earnings

Zoetis Sees 2024 Adj EPS $5.86-Adj EPS $5.92 >ZTS

4 Nov 2024, 12:05 UTC

Earnings

Zoetis 3Q Adj EPS $1.58 >ZTS

4 Nov 2024, 12:00 UTC

Earnings

Zoetis 3Q Net $682M >ZTS

4 Nov 2024, 12:00 UTC

Earnings

Zoetis 3Q EPS $1.50 >ZTS

4 Nov 2024, 12:00 UTC

Earnings

Zoetis 3Q Rev $2.39B >ZTS

6 Aug 2024, 11:44 UTC

Earnings

Zoetis Earnings Growth Picks Up, Tops Views -- IBD

6 Aug 2024, 11:09 UTC

Earnings

Zoetis Raises 2024 Operational Revenue Growth View to 9%-11% >ZTS

6 Aug 2024, 11:08 UTC

Earnings

Zoetis Raises 2024 View To Adj EPS $5.78-Adj EPS $5.88 >ZTS

6 Aug 2024, 11:08 UTC

Earnings

Zoetis Raises 2024 View To Rev $9.1B-$9.25B >ZTS

6 Aug 2024, 11:08 UTC

Earnings

Zoetis 2Q Adj EPS $1.56 >ZTS

6 Aug 2024, 11:00 UTC

Earnings

Zoetis 2Q Net $624M >ZTS

6 Aug 2024, 11:00 UTC

Earnings

Zoetis 2Q Rev $2.36B >ZTS

6 Aug 2024, 11:00 UTC

Earnings

Zoetis 2Q EPS $1.37 >ZTS

2 May 2024, 17:43 UTC

Earnings

Zoetis Stock Climbs on Earnings Beat, but Worries Linger Over Key Medicine -- Barrons.com

2 May 2024, 13:06 UTC

Earnings

Zoetis Stock Climbs on Earnings Beat, but Worries Linger Over Key Medicine -- Barrons.com

2 May 2024, 11:27 UTC

Earnings

Zoetis Earnings Top; Pet Drugmaker Rises -- IBD

2 May 2024, 11:00 UTC

Earnings

Zoetis 1Q Net $599M >ZTS

2 May 2024, 11:00 UTC

Earnings

Zoetis 1Q EPS $1.31 >ZTS

Peer Comparison

Price change

Zoetis Inc Forecast

Price Target

By TipRanks

28.29% upside

12 Months Forecast

Average 207.71 USD  28.29%

High 242 USD

Low 180 USD

Based on 8 Wall Street analysts offering 12 month price targets forZoetis Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

8 ratings

7

Buy

1

Hold

0

Sell

Technical Score

By Trading Central

161.695 / 163.24Support & Resistance

Short Term

Strong Bearish Evidence

Intermediate Term

Bearish Evidence

Long Term

Strong Bearish Evidence

Sentiment

By Acuity

87 / 386 Healthcare

News Sentiment

Bullish Evidence

Volatility

Below average

News Volume (RCV)

Above average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Zoetis Inc

Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.